: Prescription-drug costs in spotlight as pharmacy benefit reform advances in Senate 

Daily Trade

A bipartisan effort to rein in prescription drug prices advanced Thursday as a key U.S. Senate committee approved a bill aimed at reforming pharmacy benefit managers. 

PBMs are powerful middlemen who negotiate between drug companies and health insurers and can influence consumers’ and insurers’ costs for medications, patient access to drugs, and payment terms for pharmacies. 

The…

Articles You May Like

Bloomin’ Brands (BLMN) and Lovesac (LOVE): 4/6/2023 Bull & Bear
369 TIP. How Exceptional People Think w/ Polina Pompliano
Nvidia (NVDA) Stock Earnings: What Should Investors Watch For?
The Best Energy ETF Now?
Last Week ⌚ Get the Technical Analysis Course for Options Traders